Educated patients with Parkinson’s disease start treatment early

Higher Education Level, Greater Disability Associated With Treatment Timing in Parkinson’s Disease – Individuals who have higher levels of education and who are more impaired by Parkinson’s disease appear to require treatment for their symptoms earlier than do other patients, revealed by researchers.

Parkinson’s disease alters ability to learn from rewards

New findings on Parkinson’s disease and effect on patient behavior — Parkinson’s disease alters patient’s ability to learn from rewards while treatment affects ability to learn from negative outcome — research reveals possible link to depression, impulse control disorders. – Parkinson’s disease alters patient’s ability to learn from rewards while treatment affects ability to learn from negative outcome — research reveals possible link to depression, impulse control disorders.

Parkinson’s symptoms better by playing Nintendo Wii

Wii-hab may enhance Parkinson’s treatment — Parkinson’s symptoms better by playing Nintendo Wii. – Parkinson’s disease is a degenerative disease that impairs motor skills. The Nintendo Wii may help treat symptoms of Parkinson’s disease, including depression, a Medical College of Georgia researcher says.

Parkinson’s disease linked to pesticide exposure

Association found between Parkinson’s disease and pesticide exposure in French farm workers – The cause of Parkinson’s disease (PD), the second most frequent neurodegenerative disease after Alzheimer’s disease, is unknown, but in most cases it is believed to involve a combination of environmental risk factors and genetic susceptibility.

Parkinson’s disease linked to melanoma in family

Family history of melanoma linked to Parkinson’s disease – People with a family history of melanoma may have a greater risk of developing Parkinson’s disease, according to a study released today that will be presented at the American Academy of Neurology’s 61st Annual Meeting in Seattle, April 25 to May 2, 2009.

X-rays help in early diagnosis of Parkinson’s disease

X-ray eyes bring us closer to early diagnosis of Parkinson’s disease – It is estimated that 4 million people world-wide are suffering from Parkinson’s disease, a complex disease that varies greatly among affected individuals.

Parkinson’s disease genes linked to manganese poisoning

Penn study finds link between Parkinson’s disease genes and manganese poisoning – A connection between genetic and environmental causes of Parkinson’s disease has been discovered by a research team led by Aaron D. Gitler, PhD, Assistant Professor in the Department of Cell and Developmental Biology at the University of Pennsylvania School of Medicine.

Deep brain stimulation for Parkinson’s disease patients provides benefits

Deep brain stimulation treatment for advanced Parkinson’s disease patients provides benefits; But treatment also associated with increased risk of serious adverse events. – Patients with advanced Parkinson’s disease (PD) who received deep brain stimulation treatment had more improvement in movement skills and quality of life after six months than patients who received other medical therapy, but also had a higher risk of a serious adverse events, according to a study in the January 7 issue of JAMA.

Pesticides may lead to Parkinson’s disease

For the first time, the association between Parkinson’s disease and exposure to pesticides has been shown in patients with the neurological disorder compared with their unaffected relatives, according to a study in the online open access journal BMC Neurology. – The association between Parkinson’s disease and exposure to pesticides has been shown in patients with the neurological disorder compared with their unaffected relatives, according to a study in the online open access journal BMC Neurology.

Therapeutic cloning may treat Parkinson’s disease

Researchers showed that therapeutic cloning or SCNT has been successfully used to treat disease in the same subjects from whom the initial cells were derived. – Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson’s disease in mice.